Claudia Volpi
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells.
Journal: Frontiers in immunology
Published: August 06, 2025
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells.
Journal: Frontiers in immunology
Published: November 29, 2023
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function.
Journal: International journal of molecular sciences
Published: September 18, 2023
Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 21, 2023
Editorial: Heme proteins: key players in the regulation of immune responses.
Journal: Frontiers in immunology
Published: July 19, 2023
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.
Journal: Oncoimmunology
Published: February 03, 2023
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.
Journal: Frontiers in immunology
Published: December 30, 2022
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine.
Journal: eLife
Published: December 29, 2022
Optimization of Ultrasound-Assisted Extraction of Chlorogenic Acid from Potato Sprout Waste and Enhancement of the In Vitro Total Antioxidant Capacity.
Journal: Antioxidants (Basel, Switzerland)
Published: December 22, 2022
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice.
Journal: International journal of tryptophan research : IJTR
Published: November 16, 2022
Last Updated: 09/26/2026